Quantum Clovera Investama Tbk

What makes up the 28

MeasureValueBeats peers

• Value

  5Against 788 other IDX companies

  Expensive against comparable stocks.

  P/E

  Loss

  3%Cheaper than 3% of other IDX companies

  P/B

  —

  1%Cheaper than 1% of other IDX companies

  Dividend yield

  0.1%

  11%Higher than 11% of other IDX companies

• Quality

  13Against 788 other IDX companies

  Less profitable than most comparable stocks.

  Return on equity

  —

  —Not ranked

  Return on assets

  -8%

  8%Higher than 8% of other IDX companies

  Net margin

  -5.8%

  18%Higher than 18% of other IDX companies

• Growth

  7Against 788 other IDX companies

  Growing slower than most comparable stocks.

  Profit, last 4 quarters

  —

  —Not ranked

  Profit, 3-year yearly

  —

  —Not ranked

  Profit, latest quarter vs a year ago

  —

  —Not ranked

  Revenue, latest quarter vs a year ago

  -39.3%

  7%Higher than 7% of other IDX companies

• Momentum

  59Against 836 traded stocks

  Near the middle of the market over the past year.

  1-year price change

  -11.8%

  59%Better than 59% of traded stocks

• Liquidity

  69Against 836 traded stocks

  Trades more than most IDX stocks.

  Value traded per day, 30 days

  IDR 3.7B

  69%Higher than 69% of traded stocks

• Retail penalty

  −3Retail brokers XL, XC, RO, YP, past 20 sessions

  Retail is underwater here, deeper than 60% of the other stocks where it is, so 3 points come off the rating.

  Retail average buy

  18

  Close vs that average

  -18.4%

  Retail net bought

  +3.9M lots

Ownership changes

Changes reported in IDX ownership filings, including directors and major shareholders. Unchanged daily snapshots and extractions below 70% confidence are omitted.

See who is buying KREN right now

Broker flow, running trades and orderbook depth for every IDX stock, with screeners and backtests on top.

Recent IDX disclosures

Filings published on IDX in the last two years, newest first. Titles are as filed.

How this page is built